Literature DB >> 214000

Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia.

D Streja, G Steiner, P O Kwiterovich.   

Abstract

The expression of ischemic heart disease was studied in a large kindred with familial hypercholesterolemia. Tendon xanthomas, multiple generation transmission, and the appearance of bimodality in the distributions of total and low-density lipoprotein cholesterol were found. The segregation ratio was 0.9 in females and 0.43 in males, a difference first apparent during adolescence. The upper quartile of total and low-density lipoprotein cholesterol contained all but two cases of ischemic disease, whereas the lower quartile of high-density lipoprotein cholesterol contained one half of the cases. The ratio of high- to low-density lipoprotein cholesterol (range, 0.06 to 1.6) was less than or equal to 0.20 in each patient with ischemic disease. The association of a low level of high-density lipoprotein cholesterol with ischemic disease persisted after adjustment for differences in other lipids and lipoproteins. A low level of high-density lipoprotein cholesterol, as well as a high level of low-density lipoprotein cholesterol, may influence the development of ischemic heart disease in this disorder.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214000     DOI: 10.7326/0003-4819-89-6-871

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Triglyceride turnover in health and disease.

Authors:  G Steiner
Journal:  Can Med Assoc J       Date:  1979-10-20       Impact factor: 8.262

Review 2.  Clinical consequences of hyperlipidaemia.

Authors:  G R Thompson
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 3.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

Review 4.  Apolipoprotein E.

Authors:  V I Zannis; J L Breslow
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

5.  Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control.

Authors:  M F Lopes-Virella; H J Wohltmann; C B Loadholt; M G Buse
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

6.  Serum cholesterol and HDL cholesterol in childhood.

Authors:  D A Kelly; H Hooey; G Neale; A R McGill; M Stuart
Journal:  Ir J Med Sci       Date:  1981-07       Impact factor: 1.568

7.  Probucol: a weak hypocholesterolemic agent.

Authors:  M A Mishkel; S M Crowther
Journal:  Can Med Assoc J       Date:  1981-07-15       Impact factor: 8.262

8.  Assessment of long-term plasma exchange for familial hypercholesterolaemia.

Authors:  G R Thompson; N B Myant; D Kilpatrick; C M Oakley; M J Raphael; R E Steiner
Journal:  Br Heart J       Date:  1980-06

9.  Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.

Authors:  D D Sugrue; I Trayner; G R Thompson; V J Vere; J Dimeson; Y Stirling; T W Meade
Journal:  Br Heart J       Date:  1985-03

10.  A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.

Authors:  G Franceschini; C R Sirtori; A Capurso; K H Weisgraber; R W Mahley
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.